ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,599,000 | -31.3% | 113,773 | -2.3% | 0.18% | -10.4% |
| Q2 2015 | $6,699,000 | -11.9% | 116,403 | -2.6% | 0.20% | -7.4% |
| Q1 2015 | $7,607,000 | -49.4% | 119,473 | -51.0% | 0.22% | -48.3% |
| Q4 2014 | $15,043,000 | +31.1% | 243,653 | -17.5% | 0.42% | +37.7% |
| Q3 2014 | $11,471,000 | +10.2% | 295,413 | -2.3% | 0.30% | +19.6% |
| Q2 2014 | $10,412,000 | -27.8% | 302,243 | -9.5% | 0.26% | -18.8% |
| Q1 2014 | $14,423,000 | +0.6% | 333,799 | -7.3% | 0.31% | +2.6% |
| Q4 2013 | $14,343,000 | +0.7% | 360,020 | -5.1% | 0.31% | +1.3% |
| Q3 2013 | $14,242,000 | – | 379,376 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |